Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Monash IVF Group Ltd ( (AU:MVF) ) has shared an announcement.
Monash IVF Group Limited has appointed Andrew MacLachlan as the Interim Chief Financial Officer, effective immediately. This strategic move aims to bolster the company’s financial leadership while the search for a permanent CEO continues, ensuring stability and expertise in its financial operations during this transitional period.
The most recent analyst rating on (AU:MVF) stock is a Buy with a A$1.55 price target. To see the full list of analyst forecasts on Monash IVF Group Ltd stock, see the AU:MVF Stock Forecast page.
More about Monash IVF Group Ltd
Monash IVF Group Limited operates in the healthcare industry, specializing in fertility services. The company provides a range of reproductive health services, focusing on in vitro fertilization (IVF) treatments and related fertility services.
Average Trading Volume: 4,686,774
Technical Sentiment Signal: Sell
Current Market Cap: A$288.3M
For an in-depth examination of MVF stock, go to TipRanks’ Overview page.